Drew Bennett has considerable experience working with clients in the biotechnology, chemical, and pharmaceutical industries on a wide range of intellectual property issues. He assists clients with obtaining robust and enforceable patents, as well as navigating the existing patent landscape. Using his diverse experience of working with patents and applications in many foreign countries, Drew also helps clients devise effective global patent strategies designed to satisfy the distinctive requirements of foreign patent offices.
Drew has a diverse research background in the biomedical sciences, ranging from molecular immunology and antibody development to cancer immunotherapy. Prior to joining the firm, he completed his doctorate at Johns Hopkins School of Medicine where he investigated the role of immunoglobulin enhancers in B-cell development. Drew also received training in the medical entrepreneurship program at Johns Hopkins, where he collaborated with engineers to develop medical devices for low-resource areas in India.
Outside the lab and medical setting, Drew initiated a volunteer 501(c)3 non-profit in East Baltimore to serve low-income residents. In this group, the first “Community Benefits Agreement” in Baltimore City was established and resulted in jobs, training and financial considerations for the community.
Member, Practice Group of the Year, Intellectual Property, Law360 (2019)
Member, Litigation Department of the Year–Intellectual Property, The American Lawyer (2019)
NIH Ruth L. Kirschstein Research Fellowship Award (2007–2009)
NIH Intramural Program Training Award (2010–2014)
Melanie Teems Community Impact Award, Chesapeake Bay Trust (2011)
Civic Works Volunteer of the Year Award (2012)
Community Service Recognition Award, Presented by The Door, Inc. (2014)